Skip to content

Clinical trials

Phase 1 Pleural Effusion, Malignant trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pleural Effusion, Malignant Phase: Phase 1 Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20061
20091
20132
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)2
Abramson Cancer Center at Penn Medicine1
Candel Therapeutics, Inc.1
David Bartlett, MD1
H. Lee Moffitt Cancer Center and Research Institute1
M.D. Anderson Cancer Center1
University of Texas Southwestern Medical Center1
University of Virginia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pleural Effusion, Malignant14
Carcinoma, Non-Small-Cell Lung8
Lung Neoplasms5
Mesothelioma, Malignant5
Breast Neoplasms4
Esophageal Neoplasms4
Anus Neoplasms3
Bile Duct Neoplasms3
Breast Neoplasms, Male3
Carcinoma, Hepatocellular3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.